Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome

This study has been completed.

Sponsor:

Collaborator:

Novartis

Information provided by:

Children's Hospital of Philadelphia

ClinicalTrials.gov Identifier:

NCT00208026

First received: September 13, 2005

Last updated: May 9, 2008

Last verified: May 2008

History of Changes

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)

No publications provided by Children's Hospital of Philadelphia

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Yan AC, Honig PJ, Ming ME, Weber J, Shah KN. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol. 2010 Jan;146(1):57-62.

To Top